MedPath
NMPA Approval

Teicoplanin for Injection

国药准字H20253100

January 8, 2025

Drug Information

注射用替考拉宁

注射剂

0.2g (20万单位)

化学药品

January 8, 2025

Company Information

Applicant Company

北京市北京经济技术开发区永昌中路5号

Manufacturing Company

重庆市北碚区京东方大道66号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用替考拉宁 - NMPA 批准文号 | MedPath